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In a meta-analysis of testicular cancer in twins, twins had a 30% increased risk (estimate 1.31, 95% CI 1.1–1.6), providing indirect
support for the hypothesis that in utero hormone variations influence risk of testicular cancer. The summary-estimate for dizygotic
twins was 1.3 (1.0–1.7) and for monozygotic or same sex twins 1.4 (1.2–1.8).
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Testicular germ-cell cancer is either the most common or second
most common cancer in men aged 15–45, depending on country,
and rates have been increasing substantially in developed
countries over the past few decades (Huyghe et al, 2007). Despite
attempts to identify risk factors, the aetiology remains unclear.
Cryptorchidism, age (Garner et al, 2005), contra-lateral disease,
and family history (Hemminki and Chen, 2006) are the only
established risk factors. Both low and high birth weight may also
be associated (Michos et al, 2007). Evidence from animal models
(Newbold et al, 1987), and indirectly from human studies
(reviewed in Grotmol et al, 2006), indicates that the susceptibility
for testicular cancer is probably established in utero. The relative
importance of environmental factors and genetic factors are not
clear, but it is likely that both play an aetiological role (Oosterhuis
and Looijenga, 2003). Although the mechanism is uncertain, it is
thought that foetal exposure to unusually high oestrogen levels, or
an imbalance of oestrogen and androgen levels, might contribute
to an increased risk. Examining features of pregnancy, which can
affect the levels of these hormones, may help to elucidate the
aetiology of this cancer. Twinning is of interest, as twin
pregnancies, perhaps particularly with dizygotic twins, result in
higher maternal levels of serum oestrogens than with singleton
pregnancies.
Several studies have suggested an association between being a
twin and testicular cancer, but as both testicular cancer and
twinning are rare events, inferences have been limited by a lack of
precision in most studies. We therefore aimed to improve the
precision of the estimate of testicular cancer risk among twins by
carrying out a meta-analysis of previously published studies.
MATERIALS AND METHODS
Studies published in English between 1961 and 2006 were
identified through systematic searches of computerised biblio-
graphic databases (Medline and Embase) using combinations of
individual search terms and subject headings. We inspected the
reference lists of studies retrieved from these initial searches for
previously unidentified studies, which were then located on
Medline to identify their subject headings. Further searches were
then undertaken using these derived subject headings.
We included all studies that had reported the risk of testicular
cancer in twins compared with the general population or a specific
single birth control group. Some studies did not provide a risk
estimate for all male twins, instead reporting monozygotic and
dizygotic twin risks separately (Braun et al, 1995; Swerdlow et al,
1997; Verkasalo et al, 1999), but if a total estimate could be
calculated from the data provided, these studies were included.
Analyses were conducted using the meta command in Stata
(StataCorp LP, College Station, TX, USA), which tests that the true
pooled effect is zero. Tests for heterogeneity were based on the Q
statistic. Due to the small number of studies, we report on the
random effect estimates and include the overall fixed effect
estimate for completeness. Sensitivity analyses were conducted by
assessing the impact of dropping specific studies on the overall
estimated pooled effect. While acknowledging their limited power,
we used Begg’s test and Egger’s test to assess whether there was
any evidence of publication bias.
RESULTS
We identified seven studies, which met our inclusion criteria
(Table 1; Braun et al, 1995; Westergaard et al, 1998; Verkasalo
et al, 1999; Dieckmann et al, 2001; Iversen et al, 2001; Hemminki
and Chen, 2005; Neale et al, 2005). Six were cohort or retrospective
cohort studies providing relative risks (RRs) or standardised
incidence ratios (SIRs), and one (Dieckmann et al, 2001) was a
case–control study providing an odds ratio (OR). The number of
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ytesticular cancer cases ranged from 4 to 112. Two of these studies
were from Sweden and it is likely that the later study has some
overlap of study subjects with those in the earlier study.
Six of the seven studies reported an increased risk of testicular
cancer among twins (Figure 1), with two estimates being
significant (Dieckmann et al, 2001; Hemminki and Chen, 2005).
The smallest study found a non-significant decrease in risk. There
was no significant heterogeneity between studies (Q¼6.18, df¼5,
P¼0.289). The pooled estimate of risk was 1.31 (1.1–1.6)
assuming random effects and 1.34 (95% CI 1.2–1.5) assuming
fixed effects. Excluding the earlier Swedish study resulted in an
estimate of 1.3 (1.0–1.7) (P¼0.068). When we additionally
excluded the study with only four cases, we found a risk of
testicular cancer among twins of 1.4 (1.2–1.6). We conducted a
further analysis excluding the largest and smallest studies,
generating a risk estimate of 1.4 (1.1–1.7). Removing the only
case–control study did not materially alter the summary estimate.
There was no evidence of publication bias (Begg: z¼ 0.45,
P¼0.652; Egger: t¼ 0.63, P¼0.555).
Five studies either reported the dizygotic twin risk or the risks
for male twins that came from an opposite sex twin pair. Pooling
these risks resulted in a similar estimate of risks as for all twins
(OR 1.3, 95% CI 1.0–1.7). The summary estimate for monozygotic
or same sex twins was 1.4 (1.2–1.8).
DISCUSSION
Only two studies have previously found a significant positive
association between twinning and the development of testicular
cancer, with four others generating suggestive but non-significant
results and one finding a non-significant protective effect. These
analyses indicate that these are unlikely to be chance findings, that
the result is not sensitive to the inclusion/exclusion of eligible
studies, and that there is a real increase in testicular cancer among
twins.
Case–control studies have previously suggested a role for
maternal and pregnancy-related factors for the development of
testicular cancer, with speculation that high in utero oestrogen
exposure may be the underlying cause (Wanderas et al, 1998;
Richiardi et al, 2002). Twin pregnancies are associated with higher
levels of placental hormones than singleton pregnancies, and thus
this finding of a significant 30% increase in risk of testicular cancer
among twins provides indirect evidence for the in utero hormone
hypothesis.
Dizygotic mothers have a different menstrual, although not
necessarily gestational, hormonal profile than mothers of mono-
zygotic twins. A small proportion of twins will have resulted from
ovulation induction in subfertile women who may have distinctly
different cyclical hormone patterns, although their pregnancy
levels are not likely to be unusual. Some studies included here and
others not included report higher testicular cancer risks among
dizygotic than monozygotic twins (Braun et al, 1995; Swerdlow
et al, 1997), although this finding is not consistent (Verkasalo et al,
1999). Our summary estimates did not support the hypothesis
of a higher risk in dizygotic twins than monozygotic or like
sex twins, with the estimate for the latter being marginally and
not significantly higher. However about half of the like-sex
twins would be dizygotic, which could have obscured a real
difference.
Table 1 Description of studies included in the meta-analysis
First author,
year (country)
Number of
cases in twins
Number of
multiple births
SIR, RR, or OR
(all twins) (95% CI)
SIR, RR or OR
(DZ or opp. sex twins)
(95% CI)
SIR, RR, or OR
(MZ or same sex twins)
(95% CI)
Braun et al, 1995 (Sweden) 25 46767 1.42 (0.92–2.10) 1.6 (1.0–2.6) 1.1 (0.4–2.2)
Westergaard et al, 1998 (Denmark) 4 N/A 0.42 (0.16–1.12)
Verkasalo et al, 1999 (Finland) 8 25882 1.11 (0.48–2.19) 0.79 (0.22–2.03) 1.87 (0.51–4.78)
Dieckmann et al, 2001
a (Germany) 14 23 2.41 (1.04–5.63) 2.72 (0.71–11.09)
b 2.17 (0.62–7.92)
c
Iversen, 2001 (Norway) 27 23334 1.20 (0.79–1.74)
Hemminki and Chen, 2005 (Sweden) 112 139308 1.38 (1.13–1.66) 1.22 (0.85–1.70)
b 1.46 (1.15–1.83)
c
Neale et al, 2005 (United States) 14 35271 1.47 (0.73–2.95) 2.23 (0.58–8.60)
b 1.11 (0.46–2.63)
c
Summary estimates 204 270585 1.3 (1.2–1.5) 1.3 (1.0–1.7) 1.4 (1.2–1.8)
Abbreviations: OR¼odds ratio; RR¼relative risk; SIR¼standardised incidence ratio.
aCase–control study, 418 cases, 636 controls.
bZygosity determined on basis of being
opposite sex.
cSame sex twins–approximately half will be dizygotic.
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Figure 1 Relative risk of testicular cancer among male twins.
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other aspects of twin pregnancies (in particular dizygotic
pregnancies) that may alter risk of testicular cancer. These include
different levels of many other hormones and characteristics of the
mother including age, parity, and height (Blondel and Kaminski,
2002). Twins on average weigh about 1000g less than singleton
births and low birth weight may be a risk factor for testicular
cancer (Michos et al, 2007).
There is emerging evidence that being a twin is protective for
childhood cancer, possibly due to the lower birth weight of twins,
earlier limitation of their growth velocity, or the selection effects of
higher intrauterine death rates (Murphy et al, 2001; Neale et al,
2005; Milne et al, 2007). It is not yet known how far this extends
into young adulthood, although it seems likely that there is no
long-term difference in the overall risk of cancer in twins
compared with singletons (Hemminki and Chen, 2005). Hence
any isolated finding in young adulthood, such as that reported
here, is salient. These results highlight the importance of exploring
maternal factors that influence oestrogen levels, such as obesity,
that may be responsible for the rapid increase in testicular cancer
incidence that has been seen in many countries over the past
several decades.
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